ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Biosimilar Series: Part 3"
Episode Synopsis
In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval process for biosimilars, the Biologics Price Competition and Innovation Act and safety issues or adverse effects related to biosimilar use. If you have any questions for today’s guests, or have a topic you would like to hear more about, email [email protected].
More episodes of the podcast OnCall
Inflation Reduction Act: Current State
14/08/2025
Q2 GPO Legislative Townhall
31/07/2025
Inflation Reduction Act: Overview
22/07/2025
505(b)(2) Billing and Reimbursement
17/04/2025
505(b)(2) Landscape and Pipeline
03/04/2025
505(b)(2) Basics
18/03/2025
Buy and Bill: Practice Perspective
04/02/2025
Buy and Bill: The Basics
22/01/2025
In God we trust